GB9622623D0 — Dispensing devices
Assigned to Imperial Chemical Industries Ltd · Expires 1997-01-08 · 29y expired
What this patent protects
An electrostatic spraying device comprising a nozzle, means for establishing a column of material to be sprayed within a passage leading to the nozzle outlet such that the leading surface of the column is spaced from the nozzle outlet, means for pneumatically ejecting said column…
USPTO Abstract
An electrostatic spraying device comprising a nozzle, means for establishing a column of material to be sprayed within a passage leading to the nozzle outlet such that the leading surface of the column is spaced from the nozzle outlet, means for pneumatically ejecting said column or part thereof from the nozzle and means for applying high voltage to the material so that the spray formed by breaking up of the column on ejection from the nozzle are electrically charged. The column of material in the passage is preferably a discreet slug having a leading surface spaced from the nozzle outlet and a trailing surface to which air, gas or vapor under pressure can be applied to effect ejection of the slug from the nozzle.
Drugs covered by this patent
- Arnuity Ellipta (FLUTICASONE FUROATE) · Haleon Us Holdings
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.